Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

This Says Our Favorite Biotech Is Off to the Races

Shares of a promising biotech we recommended back in February 2013 – jumped as much as 27% to a three-month high of $14.20 yesterday after the company said a new cancer drug met its main goal in a midstage clinical trial.

Its shares backtracked a bit as the day progressed but still closed 17.6% higher for the session. These shares have advanced 361% since we first told you about them. The stock has generated a peak gain of 456%, making it one of the 31 recommendations we’ve made to you that have doubled or better since we launched Private Briefing in August 2011. (More on that later…)

  • Featured Story

    Four Compelling Reasons to Buy Gold Stocks Right Now

    gold stocks

    Gold prices have rallied 8% so far in 2014. It follows that investors in gold stocks - which are closely linked with gold itself - stand to profit. But the first half of 2014's gains aside, pressures shaping the yellow metal right now demand an allocation of gold stocks in a healthy investment portfolio.

    In fact, Money Morning Chief Investment Strategist Keith Fitz-Gerald said in May that the case for owning gold has never been stronger.

    "Many investors are asking themselves if now is the time to buy gold. I think that's the wrong question," Fitz-Gerald said. "What they should be asking themselves is if they can afford not to buy gold."


    Here’s why…
  • gold etfs